WSMI was invited to speak at the workshop organized by the European Directorate’s for the Quality of Medicines and Healthcare (EDQM) on 20-21 November 2014. The workshop discussed the role of good classification practices in promoting medication safety and accessibility of OTC medicines in Europe. The Directorate and its Committee of Experts on the Classification of Medicines as Regards their Supply (CD-P-PH/PHO) issues annually recommendations to health authorities of European Pharmacopoeia member states for the classification of medicines, establishes good classification practices, and collects feed-back from the different stakeholders. Nearly 100 participants from 19 countries in Europe, representing national and European competent drug authorities, ministries of health, healthcare professionals, patients’ organisations, the pharmaceutical industry and pharmaceutical wholesalers. According to the EDQM’s press release, the workshop demonstrated the interest of all stakeholders in constructive approaches to progress towards harmonisation of good classification practices for OTC medicines and ultimately promote safe and accessible medications for patients in Europe. WSMI’s presentation explained the benefits of self-care and self-medication for patients and for healthcare systems, in particular highlighting the positive impact on health outcomes when patients are engaged, and emphasized the use of the ‘Brass Model’ for assessing non-prescription medicines allowing evidence-based and transparent decision making. See E.P. Brass, R. Lofstedt and O. Renn. Improving the Decision-Making Process for Nonprescription Drugs: A Framework for Benefit-Risk Assessment. Clinical Pharmacology & Therapeutics, vol 90 2011 pp. 791-803 (Abstract only).
• Download the WSMI Zagreb Workshop Abstract (PDF 192 Kb)